Form 4: Axon COO & CFO Sells Over 4,200 Shares

Axon Enterprise's Chief Operating and Financial Officer, Brittany Bagley, sold 4,266 shares of common stock on March 2, 2026, under a pre-arranged 10b5-1 plan.

Summary

• Brittany Bagley, the Chief Operating Officer and Chief Financial Officer of Axon Enterprise, Inc., disposed of a total of 4,266 shares of the company's common stock.
• The transactions occurred on March 2, 2026, at weighted average sales prices ranging from $550.28 to $556.62 per share.
• These sales were executed pursuant to a Rule 10b5-1 trading plan, indicating they were pre-scheduled.
• Following these reported transactions, Brittany Bagley's direct beneficial ownership stands at 99,235 shares of Axon common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale reduces direct ownership, the execution under a 10b5-1 plan suggests a pre-planned liquidity event rather than a reaction to new negative company-specific information.

Positives

• The sale was conducted under a Rule 10b5-1 plan, which suggests the transaction was pre-scheduled and not a reaction to any immediate negative company-specific news.

Negatives

• An insider sale, particularly by a high-ranking officer like the COO & CFO, can sometimes be perceived negatively by the market as it reduces management's direct equity stake in the company.

Industry Context

StockSavvy.ai notes that insider sales, even those under 10b5-1 plans, are routinely monitored by investors for insights into management's confidence and potential future stock performance. In the technology and public safety solutions sector, executive stock transactions are often scrutinized for signals regarding growth prospects and valuation.

Stakeholder Impact

• Shareholders: May interpret the sale as a slight negative due to reduced insider ownership, but the 10b5-1 plan mitigates concerns about immediate negative sentiment.

Key Dates

Recommendation

The sale by a key executive, while notable, was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned diversification or liquidity event rather than a signal of deteriorating company fundamentals. Given the context, this single transaction does not warrant a change in investment thesis for Axon Enterprise, suggesting a 'hold' recommendation for existing investors.

Keywords

Axon Enterprise, AXON, Insider Sale, Form 4, Brittany Bagley, COO, CFO, Stock Sale, 10b5-1 Plan